(259 days)
Not Found
No
The device description and performance studies focus on the physical properties and performance of a topical skin adhesive, with no mention of AI or ML technologies.
Yes
The device is intended for topical application to close skin edges of wounds, which is a therapeutic purpose to aid in healing.
No
The document describes a topical skin adhesive used for wound closure, not diagnosis.
No
The device description clearly states it is a liquid topical skin adhesive contained within a plastic ampoule and applicator sleeve, indicating it is a physical product, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for topical application to hold closed skin edges of wounds. This is a direct application to the body for a physical purpose (wound closure).
- Device Description: The description details a sterile liquid adhesive that polymerizes on the skin. It mentions in vitro studies about microbial penetration, but this is a property of the adhesive itself, not a diagnostic test performed on a sample from the body.
- Lack of Diagnostic Activity: There is no mention of the device being used to test a sample (blood, urine, tissue, etc.) to diagnose a condition, monitor a disease, or determine compatibility.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnostic purposes. This device is a therapeutic device used on the body for wound closure.
N/A
Intended Use / Indications for Use
SURGISEAL Topical Skin Adhesive is intended for topical applications only to hold closed easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, simple, thoroughly cleansed, trauma induced lacerations.
SURGISEAL may be used in conjunction with, but not in place of, deep dermal sutures
Product codes (comma separated list FDA assigned to the subject device)
MPN
Device Description
SURGISEAL Twist Topical Skin Adhesives are sterile, professional liquid
topical skin adhesives containing a monomeric (2-octyl cyanoacrylate)
formulation and the colorant D & C Violet #2. Each applicator is comprised of
a plastic ampoule container contained within an applicator sleeve with the
applicator tip. This Twist applicator tray is contained in an outer Tyvek pouch.
When SURGISEAL is applied to the skin, it polymerizes in minutes.
In vitro studies have shown that SURGISEAL acts as a physical barrier to
microbial penetration as long as the adhesive film remains intact. Clinical
studies were not conducted to demonstrate microbial barrier properties and a
correlation between microbial barrier properties and a reduction in infection
have not been established.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Skin
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Professional / Not Specified
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility:
The biocompatibility testing that was previously conducted to the currently
marketed devices, SURGISEAL Stylus Twist (K130474) per the International
Standard ISO-10993, “Biological Evaluation of Medical Devices, Part 1:
Evaluation and Testing”. The existing testing is deemed supportive of the
modified device. Based on the results from those studies, the subject device is
considered to be non-toxic, non-irritating, non-sensitizing and biocompatible
and no additional biocompatibility testing was necessary.
Performance Testing:
The performance testing of SURGISEAL Twist Topical Skin Adhesive
modified product is identical to the currently marketed product; therefore the
performance testing provided in the Premarket Notification K130474 is the
same. Additional bench testing was performed to support the dimensional tip
specification modification to the currently marketed product. Bench tests
included: Flexibility, Linear and Surface Coverage, Wound Closure Strength
and Force Expression.
In all cases, the dimensional tip specification modification SURGISEAL Twist
Topical Skin Adhesive met specifications and demonstrated equivalence to the
currently marketed device.
Sterilization and Shelf-Life
The sterilization process of the dimensional tip specification modification
device remains unchanged. All products within the SURGISEAL Twist
Topical Skin Adhesive product family are sterilized in accordance with the
order of operation of the assembly. First to be sterilized is the filled ampoule
containing the adhesive, by gamma irradiation in accordance with ISO 11137-
2:2006. Then the finished bulk applicator in the secondary packaging is
sterilized by ethylene oxide in accordance with ISO 11135-1and 2:2008.
The proposed dimensional tip specification modification of SURGISEAL
Twist™ Topical Skin Adhesives does not impact the 24 month (2 year)
expiration date (shelf-life) of the currently marketing predicated devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
SURGISEAL Stylus Twist™ Topical Skin Adhesive (K130474)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4010 Tissue adhesive.
(a)
Tissue adhesive for the topical approximation of skin —(1)Identification. A tissue adhesive for the topical approximation of skin is a device intended for topical closure of surgical incisions, including laparoscopic incisions, and simple traumatic lacerations that have easily approximated skin edges. Tissue adhesives for the topical approximation of skin may be used in conjunction with, but not in place of, deep dermal stitches.(2)
Classification. Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: “Tissue Adhesive for the Topical Approximation of Skin.” See § 878.1(e) of this chapter for the availability of this guidance document.(b)
Tissue adhesive for non-topical use —(1)Identification. A tissue adhesive for non-topical use, including adhesives intended for use in the embolization of brain arteriovenous malformation or for use in ophthalmic surgery, is a device used for adhesion of internal tissues and vessels.(2)
Classification. Class III (premarket approval). As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 878.3 of this chapter.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 9, 2014
Adhezion Biomedical, LLC Ms. Caridad Smith Director of Regulatory Affairs and Quality Assurance One Meridian Boulevard, Suite 1B02 Wyomissing, Pennsylvania 19610
Re: K133963
Trade/Device Name: SURGISEAL Twist" Topical Skin Adhesive Regulation Number: 21 CFR 878.4010 Regulation Name: Tissue Adhesive Regulatory Class: Class II Product Code: MPN Dated: August 13, 2014 Received: August 14, 2014
Dear Ms. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
1
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
David Krause -S
- Binita S. Ashar, M.D., M.B.A., F.A.C.S. for Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K133963
Device Name SURGISEAL Twist™ Topical Skin Adhesive
Indications for Use (Describe)
SURGISEAL Topical Skin Adhesive is intended for topical applications only to hold closed easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, simple, thoroughly cleansed, trauma induced lacerations.
SURGISEAL may be used in conjunction with, but not in place of, deep dermal sutures
Type of Use (Select one or both, as applicable)
2 Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Adhezion BIOMEDICAL. The logo consists of a blue abstract design on the left, resembling curved lines or waves. To the right of the design is the word "Adhezion" in a dark blue, sans-serif font. Below "Adhezion" is the word "BIOMEDICAL" in a smaller, lighter blue font.
510(k) Summary
A summary of 510(k) safety and effectiveness information in accordance with the requirements of 21 CFR 807.92 is below:
| Submitter Information: | |
|---|---|
| Name | Adhezion Biomedical, LLC |
| Address | One Meridian Boulevard |
| Suite 1B02 | |
| Wyomissing, PA 19610 | |
| Phone Number | (828) 572-4201 |
| Fax Number | (828) 726-7117 |
| Establishment Registration | 3006385287 |
| Name of contact person(s) | Caridad Smith – Director of Regulatory Affairs/Quality Assurance |
| Tracy Lofgren – Regulatory Consultant | |
| Date prepared | August 27, 2014 |
| Name of Device: | |
| Trade or proprietary names | SURGISEAL Twist™ Topical Skin Adhesive |
| Common or usual name | Device, Tissue Adhesive for Topical Approximation |
| Classification name | Class II |
| Classification Panel | General and Plastic Surgery Devices |
| Regulation | Class II, under 21 CFR 878.4010 |
| Product Code(s) | MPN |
| Legally Marketed device(s) to which equivalence is claimed | SURGISEAL Stylus Twist™ Topical Skin Adhesive (K130474) |
| Reason for 510(k) submission | Device Modification – Dimensional Specification Change to Tip |
| Device Description | SURGISEAL Twist Topical Skin Adhesives are sterile, professional liquid |
| topical skin adhesives containing a monomeric (2-octyl cyanoacrylate) | |
| formulation and the colorant D & C Violet #2. Each applicator is comprised of | |
| a plastic ampoule container contained within an applicator sleeve with the | |
| applicator tip. This Twist applicator tray is contained in an outer Tyvek pouch. | |
| When SURGISEAL is applied to the skin, it polymerizes in minutes. |
In vitro studies have shown that SURGISEAL acts as a physical barrier to
microbial penetration as long as the adhesive film remains intact. Clinical
studies were not conducted to demonstrate microbial barrier properties and a
correlation between microbial barrier properties and a reduction in infection
have not been established. |
| Indications for use | SURGISEAL Twist Topical Skin Adhesive is intended for topical applications
only to hold closed easily approximated skin edges of wounds from surgical
incisions, including punctures from minimally invasive surgery, simple,
thoroughly cleansed, trauma induced lacerations.
SURGISEAL may be used in conjunction with, but not in place of, deep
dermal sutures. |
| Technological
Characteristics | The technological characteristics of SURGISEAL Stylus Twist and
SURGISEAL Twist Topical Skin Adhesives are equivalent in performance.
SURGISEAL Twist consists of a monomeric (2-octyl cyanoacrylate) liquid
adhesive formulation packaged in a single-use applicator. The device is a low
viscosity formulation to allow for varied layered applications of the adhesive to
the intended area and allow for either a single thick, continuous layer or two
thin layers of the adhesive to the wound area.
The smaller tip dimensions of the SURGISEAL Twist applicator is the only
difference between the subject and predicate devices. |
| Substantial
Equivalence | Biocompatibility:
The biocompatibility testing that was previously conducted to the currently
marketed devices, SURGISEAL Stylus Twist (K130474) per the International
Standard ISO-10993, “Biological Evaluation of Medical Devices, Part 1:
Evaluation and Testing”. The existing testing is deemed supportive of the
modified device. Based on the results from those studies, the subject device is
considered to be non-toxic, non-irritating, non-sensitizing and biocompatible
and no additional biocompatibility testing was necessary.
Performance Testing:
The performance testing of SURGISEAL Twist Topical Skin Adhesive
modified product is identical to the currently marketed product; therefore the
performance testing provided in the Premarket Notification K130474 is the
same. Additional bench testing was performed to support the dimensional tip
specification modification to the currently marketed product. Bench tests
included: Flexibility, Linear and Surface Coverage, Wound Closure Strength
and Force Expression.
In all cases, the dimensional tip specification modification SURGISEAL Twist
Topical Skin Adhesive met specifications and demonstrated equivalence to the
currently marketed device.
Sterilization and Shelf-Life
The sterilization process of the dimensional tip specification modification |
| device remains unchanged. All products within the SURGISEAL Twist | |
| Topical Skin Adhesive product family are sterilized in accordance with the | |
| order of operation of the assembly. First to be sterilized is the filled ampoule | |
| containing the adhesive, by gamma irradiation in accordance with ISO 11137- | |
| 2:2006. Then the finished bulk applicator in the secondary packaging is | |
| sterilized by ethylene oxide in accordance with ISO 11135-1and 2:2008. | |
| The proposed dimensional tip specification modification of SURGISEAL
Twist™ Topical Skin Adhesives does not impact the 24 month (2 year)
expiration date (shelf-life) of the currently marketing predicated devices. | |
4
Image /page/4/Picture/0 description: The image shows the logo for Adhezion Biomedical. The logo consists of a stylized graphic to the left of the company name. The graphic is made up of several curved lines in a light blue color. The company name is written in a dark blue font, with the word "Adhezion" on top and the word "BIOMEDICAL" underneath.
5
Image /page/5/Picture/0 description: The image shows the logo for Adhezion Biomedical. The logo consists of a stylized graphic to the left of the company name. The graphic is made up of several curved lines in shades of blue. The company name "Adhezion" is in a dark blue sans-serif font, with the word "BIOMEDICAL" in a smaller, lighter blue font underneath.
Based on bench performance testing, the specification of the device, SURGISEAL Twist has demonstrated to be substantially equivalent to its currently marketed device from a safety and performance perspective, and has demonstrated that a dimensional tip modification to the product maintains approximation of wound edges.